Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study (2021)
Attributed to:
Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.07.14.21260497
Publication URI: http://dx.doi.org/10.1101/2021.07.14.21260497
Type: Preprint